COMPANY
Arch Therapeutics
Timeline
- Trial start Not phased (device or behavioral study): Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers source ↗
- Trial start Not phased (device or behavioral study): Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06028386 | Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | Aug 15, 2023 | Apr 30, 2024 (estimated) |
| NCT02704104 | Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions | Not phased (device or behavioral study) | Completed | 2016-02 | 2016-06 (actual) |